HIGHLIGHTS
- who: Lillemor Berntson from the (UNIVERSITY) have published the research work: Severe Raynaudu2019s phenomenon from ethosuximide raised concern over possible onset of systemic vasculitis: a case report, in the Journal: (JOURNAL)
- what: Still, introduction of prednisolone after the diagnostic work-up, to decrease the activity of possible vasculitis, was considered inevitable.
SUMMARY
In pediatric rheumatology, RP may occur in various inflammatory systemic diseases, but a more severe presentation is most commonly part of a mixed connective tissue disease or juvenile systemic scleroderma. Adverse events in ethosuximide treatment have mostly been associated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.